Aspirin-Free Strategy After 3-6 Month Dual Antiplatelet Therapy in Acute Coronary Syndrome

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 300 participants.

Also called NCT07736196

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07736196
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07736196. Randomized; no masking; primary purpose treatment. Start 2026-07-15 (anticipated); primary completion 2029-07-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Aspirin-Free Strategy After 3-6 Month Dual Antiplatelet Therapy in Acute Coronary Syndrome
Condition
Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI (percutaneous coronary intervention))
Condition
Dual Anti-platelet Therapy
Intervention (Drug)
Aspirin-Free Strategy
Intervention (Drug)
Dual Antiplatelet Therapy
Lead sponsor
Assiut University (class: other)

Record details

Record id
cardio:ct-nct07736196
Content hash
1311fddb13cb8c36d11c625e4c21a60348ca08343fdd50557db54d7fcfb1574e